Skip to main content
. 2020 Sep 10;94(12):4159–4172. doi: 10.1007/s00204-020-02895-z

Fig. 1.

Fig. 1

a Cytotoxicity and micronuclei formation in HepG2 cells (upper left), HepG2-CYP3A4 cells (upper right) and micronuclei levels (lower, bars) in HepG2-CYP3A4 cells treated with  senecionine. The cytotoxicity in HepG2-CYP3A4 cells under the conditions of the micronuclei assay (with recovery) is also shown (-■-). Data represent mean ± S.D. from n = 3 independent experiments. b Cytotoxicity and micronuclei formation in HepG2 cells (upper left), HepG2-CYP3A4 cells (upper right) and micronuclei levels (lower, bars) in HepG2-CYP3A4 cells treated with  lycopsamine. The cytotoxicity in HepG2-CYP3A4 cells under the conditions of the micronuclei assay (with recovery) is also shown (-■-). Data represent mean ± S.D. from n = 3 independent experiments